Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Mapping child and adolescent self-reported symptom data to clinician-reported adverse event grading to improve pediatric oncology care and research.

McFatrich M, Brondon J, Lucas NR, Hinds PS, Maurer SH, Mack JW, Freyer DR, Jacobs SS, Baker JN, Mowbray C, Wang M, Castellino SM, Barz Leahy A, Reeve BB.

Cancer. 2019 Sep 25. doi: 10.1002/cncr.32525. [Epub ahead of print]

PMID:
31553494
2.

Obesity and Risk for Second Malignant Neoplasms in Childhood Cancer Survivors: A Case-Control Study Utilizing the California Cancer Registry.

Moke DJ, Hamilton AS, Chehab L, Deapen D, Freyer DR.

Cancer Epidemiol Biomarkers Prev. 2019 Oct;28(10):1612-1620. doi: 10.1158/1055-9965.EPI-19-0466. Epub 2019 Jul 23.

PMID:
31337641
3.

Evaluating and providing quality health information for adolescents and young adults with cancer.

Grace JG, Schweers L, Anazodo A, Freyer DR.

Pediatr Blood Cancer. 2019 Oct;66(10):e27931. doi: 10.1002/pbc.27931. Epub 2019 Jul 19. Review.

PMID:
31322817
4.

Emerging Cancer Survival Trends, Disparities, and Priorities in Adolescents and Young Adults: A California Cancer Registry-Based Study.

Moke DJ, Tsai K, Hamilton AS, Hwang A, Liu L, Freyer DR, Deapen D.

JNCI Cancer Spectr. 2019 Jun;3(2):pkz031. doi: 10.1093/jncics/pkz031. Epub 2019 Jun 12.

5.

Interventions for cisplatin-induced hearing loss in children and adolescents with cancer.

Freyer DR, Brock P, Knight K, Reaman G, Cabral S, Robinson PD, Sung L.

Lancet Child Adolesc Health. 2019 Aug;3(8):578-584. doi: 10.1016/S2352-4642(19)30115-4. Epub 2019 May 31. Review.

PMID:
31160205
6.

Transitional care practices, services, and delivery in childhood cancer survivor programs: A survey study of U.S. survivorship providers.

Sadak KT, Szalda D, Lindgren BR, Kinahan KE, Eshelman-Kent D, Schwartz LA, Henderson T, Freyer DR.

Pediatr Blood Cancer. 2019 Aug;66(8):e27793. doi: 10.1002/pbc.27793. Epub 2019 May 16.

PMID:
31099145
7.

Response to Siegel et al.

Liu L, Moke DJ, Tsai KY, Hwang A, Freyer DR, Hamilton AS, Zhang J, Cockburn M, Deapen D.

J Natl Cancer Inst. 2019 Feb 21. pii: djz025. doi: 10.1093/jnci/djz025. [Epub ahead of print] No abstract available.

PMID:
30793169
8.

Understanding, measuring, and addressing the financial impact of cancer on adolescents and young adults.

Salsman JM, Bingen K, Barr RD, Freyer DR.

Pediatr Blood Cancer. 2019 Jul;66(7):e27660. doi: 10.1002/pbc.27660. Epub 2019 Feb 12. Review.

PMID:
30756484
9.

A Reappraisal of Sex-Specific Cancer Survival Trends Among Adolescents and Young Adults in the United States.

Liu L, Moke DJ, Tsai KY, Hwang A, Freyer DR, Hamilton AS, Zhang J, Cockburn M, Deapen D.

J Natl Cancer Inst. 2019 May 1;111(5):509-518. doi: 10.1093/jnci/djy140.

10.

A prospective comparison of cancer clinical trial availability and enrollment among adolescents/young adults treated at an adult cancer hospital or affiliated children's hospital.

Thomas SM, Malvar J, Tran HH, Shows JT, Freyer DR.

Cancer. 2018 Oct 15;124(20):4064-4071. doi: 10.1002/cncr.31727. Epub 2018 Oct 6.

11.

Sodium Thiosulfate and Cisplatin-Induced Hearing Loss.

Freyer DR, Frazier AL, Sung L.

N Engl J Med. 2018 Sep 20;379(12):1180-1. doi: 10.1056/NEJMc1809501. No abstract available.

PMID:
30260148
12.

A comparative analysis of clinicopathological features and survival among early adolescents/young adults and children with low-grade glioma: a report from the Children's Oncology Group.

Margol AS, Yeo KK, Xia C, Onar A, Robison NJ, Freyer DR, Dhall G.

J Neurooncol. 2018 Dec;140(3):575-582. doi: 10.1007/s11060-018-2983-5. Epub 2018 Sep 1.

13.

Childhood Cancer Survivorship and Substance Use Behaviors: A Matched Case-Control Study Among Hispanic Adolescents and Young Adults.

Milam J, Slaughter R, Tobin JL, Unger JB, Ritt-Olson A, Freyer DR, Soto D, Hamilton AS.

J Adolesc Health. 2018 Jul;63(1):115-117. doi: 10.1016/j.jadohealth.2018.02.005.

14.

Treatment of young adults with Philadelphia-negative acute lymphoblastic leukemia and lymphoblastic lymphoma: Hyper-CVAD vs. pediatric-inspired regimens.

Siegel SE, Advani A, Seibel N, Muffly L, Stock W, Luger S, Shah B, DeAngelo DJ, Freyer DR, Douer D, Johnson RH, Hayes-Lattin B, Lewis M, Jaboin JJ, Coccia PF, Bleyer A.

Am J Hematol. 2018 Oct;93(10):1254-1266. doi: 10.1002/ajh.25229. Epub 2018 Sep 3. Review.

15.

Treatment strategies for adolescent and young adult patients with acute myeloid leukemia.

O'Dwyer K, Freyer DR, Horan JT.

Blood. 2018 Jul 26;132(4):362-368. doi: 10.1182/blood-2017-12-778472. Epub 2018 Jun 12. Review.

PMID:
29895667
16.

Prevention of cisplatin-induced hearing loss in children: Informing the design of future clinical trials.

Minasian LM, Frazier AL, Sung L, O'Mara A, Kelaghan J, Chang KW, Krailo M, Pollock BH, Reaman G, Freyer DR.

Cancer Med. 2018 May 30. doi: 10.1002/cam4.1563. [Epub ahead of print]

17.

Pediatric-Inspired Treatment Regimens for Adolescents and Young Adults With Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: A Review.

Siegel SE, Stock W, Johnson RH, Advani A, Muffly L, Douer D, Reed D, Lewis M, Freyer DR, Shah B, Luger S, Hayes-Lattin B, Jaboin JJ, Coccia PF, DeAngelo DJ, Seibel N, Bleyer A.

JAMA Oncol. 2018 May 1;4(5):725-734. doi: 10.1001/jamaoncol.2017.5305. Review.

PMID:
29450465
18.

Sexual functioning among young adult cancer patients: A 2-year longitudinal study.

Acquati C, Zebrack BJ, Faul AC, Embry L, Aguilar C, Block R, Hayes-Lattin B, Freyer DR, Cole S.

Cancer. 2018 Jan 15;124(2):398-405. doi: 10.1002/cncr.31030. Epub 2017 Nov 17.

19.

A prospective, observational cohort study comparing cancer clinical trial availability and enrollment between early adolescents/young adults and children.

Thomas SM, Malvar J, Tran H, Shows J, Freyer DR.

Cancer. 2018 Mar 1;124(5):983-990. doi: 10.1002/cncr.31127. Epub 2017 Nov 17.

20.

Prevalence and correlates of health information-seeking among Hispanic and non-Hispanic childhood cancer survivors.

Miller KA, Ramirez CN, Wojcik KY, Ritt-Olson A, Baezconde-Garbanati L, Thomas SM, Freyer DR, Hamilton AS, Milam JE.

Support Care Cancer. 2018 Apr;26(4):1305-1313. doi: 10.1007/s00520-017-3956-5. Epub 2017 Nov 9.

21.
22.

Child and adolescent self-report symptom measurement in pediatric oncology research: a systematic literature review.

Pinheiro LC, McFatrich M, Lucas N, Walker JS, Withycombe JS, Hinds PS, Sung L, Tomlinson D, Freyer DR, Mack JW, Baker JN, Reeve BB.

Qual Life Res. 2018 Feb;27(2):291-319. doi: 10.1007/s11136-017-1692-4. Epub 2017 Sep 6. Review.

23.

Identifying metrics of success for transitional care practices in childhood cancer survivorship: A qualitative study of survivorship providers.

Sadak KT, Neglia JP, Freyer DR, Harwood E.

Pediatr Blood Cancer. 2017 Nov;64(11). doi: 10.1002/pbc.26587. Epub 2017 May 30.

PMID:
28557375
24.

A randomized controlled trial testing an adherence-optimized Vitamin D regimen to mitigate bone change in adolescents being treated for acute lymphoblastic leukemia.

Orgel E, Mueske NM, Sposto R, Gilsanz V, Wren TAL, Freyer DR, Butturini AM, Mittelman SD.

Leuk Lymphoma. 2017 Oct;58(10):2370-2378. doi: 10.1080/10428194.2017.1289526. Epub 2017 Feb 20.

25.

Cognitive Interview-Based Validation of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in Adolescents with Cancer.

Reeve BB, McFatrich M, Pinheiro LC, Freyer DR, Basch EM, Baker JN, Withycombe JS, Sung L, Mack JW, Waldron MK, Mowbray C, Palma D, Hinds PS.

J Pain Symptom Manage. 2017 Apr;53(4):759-766. doi: 10.1016/j.jpainsymman.2016.11.006. Epub 2017 Jan 3.

26.

Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial.

Freyer DR, Chen L, Krailo MD, Knight K, Villaluna D, Bliss B, Pollock BH, Ramdas J, Lange B, Van Hoff D, VanSoelen ML, Wiernikowski J, Neuwelt EA, Sung L.

Lancet Oncol. 2017 Jan;18(1):63-74. doi: 10.1016/S1470-2045(16)30625-8. Epub 2016 Dec 1. Erratum in: Lancet Oncol. 2017 Jun;18(6):e301.

27.

Development of a Culturally Competent Service to Improve Academic Functioning for Latino Survivors of Acute Lymphoblastic Leukemia: Methodological Considerations.

Bava L, Johns A, Freyer DR, Ruccione K.

J Pediatr Oncol Nurs. 2017 May/Jun;34(3):222-229. doi: 10.1177/1043454216676837. Epub 2016 Nov 26.

PMID:
27889691
28.

Substance use among adolescent and young adult cancer survivors.

Milam J, Slaughter R, Meeske K, Ritt-Olson A, Sherman-Bien S, Freyer DR, Kuperberg A, Hamilton AS.

Psychooncology. 2016 Nov;25(11):1357-1362. doi: 10.1002/pon.3958. Epub 2015 Aug 27.

29.

Eliciting the child's voice in adverse event reporting in oncology trials: Cognitive interview findings from the Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events initiative.

Reeve BB, McFatrich M, Pinheiro LC, Weaver MS, Sung L, Withycombe JS, Baker JN, Mack JW, Waldron MK, Gibson D, Tomlinson D, Freyer DR, Mowbray C, Jacobs S, Palma D, Martens CE, Gold SH, Jackson KD, Hinds PS.

Pediatr Blood Cancer. 2017 Mar;64(3). doi: 10.1002/pbc.26261. Epub 2016 Sep 21.

30.

Supporting long-term follow-up of young adult survivors of childhood cancer: Correlates of healthcare self-efficacy.

Miller KA, Wojcik KY, Ramirez CN, Ritt-Olson A, Freyer DR, Hamilton AS, Milam JE.

Pediatr Blood Cancer. 2017 Feb;64(2):358-363. doi: 10.1002/pbc.26209. Epub 2016 Aug 27.

31.

A parent-directed intervention for addressing academic risk in Latino survivors of childhood leukemia: results of a pilot study.

Bava L, Malvar J, Sposto R, Okada M, Gonzalez-Morkos B, Schweers LM, Nuñez C, Ruccione K, Katz ER, Freyer DR.

Psychooncology. 2016 Oct;25(10):1246-1249. doi: 10.1002/pon.4188. Epub 2016 Jul 4. No abstract available.

PMID:
27271226
32.

Nonrandomized comparison of neurofibromatosis type 1 and non-neurofibromatosis type 1 children who received carboplatin and vincristine for progressive low-grade glioma: A report from the Children's Oncology Group.

Ater JL, Xia C, Mazewski CM, Booth TN, Freyer DR, Packer RJ, Sposto R, Vezina G, Pollack IF.

Cancer. 2016 Jun 15;122(12):1928-36. doi: 10.1002/cncr.29987. Epub 2016 Apr 8.

33.

Low Enrollment of Adolescents and Young Adults Onto Cancer Trials: Insights From the Community Clinical Oncology Program.

Roth ME, O'Mara AM, Seibel NL, Dickens DS, Langevin AM, Pollock BH, Freyer DR.

J Oncol Pract. 2016 Apr;12(4):e388-95. doi: 10.1200/JOP.2015.009084. Epub 2016 Mar 29.

34.

Early injury to cortical and cancellous bone from induction chemotherapy for adolescents and young adults treated for acute lymphoblastic leukemia.

Orgel E, Mueske NM, Wren TA, Gilsanz V, Butturini AM, Freyer DR, Mittelman SD.

Bone. 2016 Apr;85:131-7. doi: 10.1016/j.bone.2016.01.027. Epub 2016 Feb 3.

35.

Next steps for adolescent and young adult oncology workshop: An update on progress and recommendations for the future.

Smith AW, Seibel NL, Lewis DR, Albritton KH, Blair DF, Blanke CD, Bleyer WA, Freyer DR, Geiger AM, Hayes-Lattin B, Tricoli JV, Wagner LI, Zebrack BJ.

Cancer. 2016 Apr 1;122(7):988-99. doi: 10.1002/cncr.29870. Epub 2016 Feb 5. Review.

36.

Limitations of body mass index to assess body composition due to sarcopenic obesity during leukemia therapy.

Orgel E, Mueske NM, Sposto R, Gilsanz V, Freyer DR, Mittelman SD.

Leuk Lymphoma. 2018 Jan;59(1):138-145. doi: 10.3109/10428194.2015.1136741. Epub 2016 Jan 27.

37.

Reconsidering Physical Activity Restrictions for Mononephric Survivors of Childhood Cancer: A Report From the Children's Oncology Group.

Okada M, Hockenberry MJ, Koh CJ, Meeske KA, Rangan KE, Rodgers C, Rosenthal Y, Ruccione KS, Freyer DR.

J Pediatr Oncol Nurs. 2016 Jul;33(4):306-13. doi: 10.1177/1043454215607341. Epub 2015 Nov 20. Review.

38.

Effect of Sensorineural Hearing Loss on Neurocognitive Functioning in Pediatric Brain Tumor Survivors.

Orgel E, O'Neil SH, Kayser K, Smith B, Softley TL, Sherman-Bien S, Counts PA, Murphy D, Dhall G, Freyer DR.

Pediatr Blood Cancer. 2016 Mar;63(3):527-34. doi: 10.1002/pbc.25804. Epub 2015 Nov 3.

39.

Enhancing Adolescent and Young Adult Oncology Research Within the National Clinical Trials Network: Rationale, Progress, and Emerging Strategies.

Weiss AR, Nichols CR, Freyer DR.

Semin Oncol. 2015 Oct;42(5):740-7. doi: 10.1053/j.seminoncol.2015.07.012. Epub 2015 Jul 10. Review.

40.

Case-linked analysis of clinical trial enrollment among adolescents and young adults at a National Cancer Institute-designated comprehensive cancer center.

Collins CL, Malvar J, Hamilton AS, Deapen DM, Freyer DR.

Cancer. 2015 Dec 15;121(24):4398-406. doi: 10.1002/cncr.29669. Epub 2015 Sep 22.

41.

Early Cardiac Iron Overload in a Child on Treatment of Acute Lymphoblastic Leukemia.

Reitman AJ, Coates TD, Freyer DR.

Pediatrics. 2015 Sep;136(3):e697-700. doi: 10.1542/peds.2014-3770. Epub 2015 Aug 17.

42.

Inclusion of Adolescents and Young Adults in Cancer Clinical Trials.

Weiss AR, Hayes-Lattin B, Kutny MA, Stock W, Stegenga K, Freyer DR.

Semin Oncol Nurs. 2015 Aug;31(3):197-205. doi: 10.1016/j.soncn.2015.05.001. Epub 2015 May 7. Review.

43.

Comparative Toxicity by Sex Among Children Treated for Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group.

Meeske KA, Ji L, Freyer DR, Gaynon P, Ruccione K, Butturini A, Avramis VI, Siegel S, Matloub Y, Seibel NL, Sposto R.

Pediatr Blood Cancer. 2015 Dec;62(12):2140-9. doi: 10.1002/pbc.25628. Epub 2015 Jul 14.

44.

The Clinical Trials Gap for Adolescents and Young Adults with Cancer: Recent Progress and Conceptual Framework for Continued Research.

Freyer DR, Seibel NL.

Curr Pediatr Rep. 2015 Jun;3(2):137-145. doi: 10.1007/s40124-015-0075-y. Epub 2015 Feb 18.

45.

Late Mortality After Dexrazoxane Treatment: A Report From the Children's Oncology Group.

Chow EJ, Asselin BL, Schwartz CL, Doody DR, Leisenring WM, Aggarwal S, Baker KS, Bhatia S, Constine LS, Freyer DR, Lipshultz SE, Armenian SH.

J Clin Oncol. 2015 Aug 20;33(24):2639-45. doi: 10.1200/JCO.2014.59.4473. Epub 2015 May 26.

46.

Institutional adherence to cardiovascular risk factor screening guidelines for young survivors of acute lymphoblastic leukemia.

Lin MH, Wood JR, Mittelman SD, Freyer DR.

J Pediatr Hematol Oncol. 2015 May;37(4):e253-7. doi: 10.1097/MPH.0000000000000320.

PMID:
25757021
47.

Obesity is associated with residual leukemia following induction therapy for childhood B-precursor acute lymphoblastic leukemia.

Orgel E, Tucci J, Alhushki W, Malvar J, Sposto R, Fu CH, Freyer DR, Abdel-Azim H, Mittelman SD.

Blood. 2014 Dec 18;124(26):3932-8. doi: 10.1182/blood-2014-08-595389. Epub 2014 Oct 27.

PMID:
25349177
48.

Cancer-related follow-up care among Hispanic and non-Hispanic childhood cancer survivors: The Project Forward study.

Milam JE, Meeske K, Slaughter RI, Sherman-Bien S, Ritt-Olson A, Kuperberg A, Freyer DR, Hamilton AS.

Cancer. 2015 Feb 15;121(4):605-13. doi: 10.1002/cncr.29105. Epub 2014 Oct 23.

49.

Characterization of transfusion-derived iron deposition in childhood cancer survivors.

Ruccione KS, Wood JC, Sposto R, Malvar J, Chen C, Freyer DR.

Cancer Epidemiol Biomarkers Prev. 2014 Sep;23(9):1913-9. doi: 10.1158/1055-9965.EPI-14-0292. Epub 2014 Jun 24.

50.

Screening for cardiac dysfunction in anthracycline-exposed childhood cancer survivors.

Armenian SH, Gelehrter SK, Vase T, Venkatramani R, Landier W, Wilson KD, Herrera C, Reichman L, Menteer JD, Mascarenhas L, Freyer DR, Venkataraman K, Bhatia S.

Clin Cancer Res. 2014 Dec 15;20(24):6314-23. doi: 10.1158/1078-0432.CCR-13-3490. Epub 2014 Jun 19.

Supplemental Content

Loading ...
Support Center